Gilead Sciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 1GILD.MI | BMY | GLAXO.BO | BIIB | SNY | GSK | |
|---|---|---|---|---|---|---|
| Market cap | 159.56B | 133.70B | 423.63B | 37.62B | 114.01B | 102.53B |
| P/E (TTM) | — | 14.5 | 44.4 | 110.2 | 23.7 | 17.8 |
| Forward P/E | — | 9.8 | 36.9 | 15.7 | 8.9 | 10.3 |
| Price/book | 13.8 | 5.7 | 24.8 | 2.0 | 1.4 | 4.1 |
| Dividend yield | 1.90% | 3.93% | 1.75% | — | 5.10% | 3.55% |
| 1-year change | +44.65% | +37.66% | +6.17% | +62.35% | −4.08% | +8.60% |
| Today | −2.22% | +1.90% | −1.26% | +0.01% | +0.23% | 0.00% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All 1GILD.MI news ›Gilead Sciences (GILD) Receives a Buy from Morgan Stanley
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades. In a report released today, Terence Flynn from Morgan Stanley assigned a Buy rating to Gilead Sciences, with a price target…
More from 1 other outlet
Gilead Sciences (GILD) Receives a Rating Update from a Top Analyst
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades. TD Cowen analyst Tyler Van Buren maintained a Buy rating on Gilead Sciences today and set a price target of $175.00. Van…
Gilead Sciences declares $0.82 dividend
Gilead Sciences declares a $0.82 quarterly dividend with a 1.92% forward yield. - Gilead Sciences (GILD) declares $0.82/share quarterly dividend, in line with previous. - Payable Dec. 30; for shareholders of record Dec. 15; ex-div Dec. 15.
What Is Drawing Attention Toward Gilead Sciences (NASDAQ:GILD) Today?
Can Sempra (NYSE:SRE) Sustain Its Momentum Across Utility Stocks? Market watchers have framed the company as the dominant force in HIV medicine, a position the prevention franchise aims to deepen. That framing has kept the stock near the…
Gilead Sciences, Inc. $GILD Stock Sold by Hennessy Advisors Inc.
MarketBeat Gilead Sciences, Inc. $GILD Stock Sold by Hennessy Advisors Inc. - Hennessy Advisors reduced its Gilead Sciences position by 21.6% in the third quarter, selling 18,399 shares and retaining 66,800 shares valued at approximate
GILEAD SCIENCES ($GILD) Releases Q3 2026 Earnings, Stock Rises
GILEAD SCIENCES ($GILD) posted quarterly earnings results for Q3 2026 on Thursday, October 29th. The company reported earnings of $2.55 per share, beating estimates of $2.24 by $0.31. The company also reported revenue of $8,300,000,000,…
Gilead Sciences, Inc. $GILD Holdings Lowered by Conning Inc.
Get Our Latest Stock Analysis on GILD Gilead Sciences, Inc is a biopharmaceutical company that discovers, develops and commercializes medicines for serious and life-threatening diseases. The company is best known for its HIV treatments,…
Gilead Sciences (NASDAQ:GILD) Stock Price Target Raised at Royal Bank Of Canada
MarketBeat Gilead Sciences (NASDAQ:GILD) Stock Price Target Raised at Royal Bank Of Canada - Royal Bank of Canada raised Gilead Sciences’ price target to $131 from $126 while maintaining a “sector perform” rating, imply
Gilead Sciences, Inc (Derivatives) priceGILD#7859
Gilead Sciences, Inc (Derivatives) price today, GILD to USD live price, marketcap and chart CoinMarketCap The live Gilead Sciences, Inc (Derivatives) price today is $171.11 USD with a 24-hour trading volume of not available. We update our…
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viridian Therapeutics (VRDN), Align Tech (ALGN) and Gilead Sciences (GILD)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Viridian Therapeutics (VRDN), Align Tech (ALGN) and Gilead Sciences (GILD). Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Viridian…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com28
- marketbeat.com15
- defenseworld.net6
- stocktitan.net6
- seekingalpha.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 114 articles, not a forecast.